TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Atomo Diagnostics Ltd. ( (AU:AT1) ).
Atomo Diagnostics Ltd. announced the adoption of an amended constitution, as approved by its shareholders at the recent Annual General Meeting. This change reflects the company’s ongoing commitment to aligning its governance framework with its operational and strategic objectives, potentially impacting its market positioning and stakeholder engagement.
More about Atomo Diagnostics Ltd.
Atomo Diagnostics Ltd. is an Australian-headquartered medical device company that provides unique, integrated rapid diagnostic test devices to the global market. The company’s patented devices are designed to simplify testing procedures, enhance usability, and improve reliability for both point-of-care and at-home testing applications. Atomo has commercialized several products internationally and has supply agreements for testing applications targeting infectious diseases such as COVID-19, HIV, and others.
Average Trading Volume: 1,893,811
Technical Sentiment Signal: Buy
Current Market Cap: A$22.68M
Learn more about AT1 stock on TipRanks’ Stock Analysis page.